These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12132367)
1. [Barrett's esophagus]. Dolina J; Hep A; Dítĕ P; Münzová H; Kunovská M; Husová L; Plottová Z Vnitr Lek; 2002 Jun; 48(6):587-90. PubMed ID: 12132367 [TBL] [Abstract][Full Text] [Related]
2. [Barrett's esophagus]. Dolina J; Hep A; Dite P; Munzova H; Kunovska M; Husova L; Vlckova F; Pilottova Z Bratisl Lek Listy; 2000; 101(6):321-3. PubMed ID: 11039203 [TBL] [Abstract][Full Text] [Related]
3. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Gerson LB; Boparai V; Ullah N; Triadafilopoulos G Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912 [TBL] [Abstract][Full Text] [Related]
4. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565 [TBL] [Abstract][Full Text] [Related]
5. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus. Jankowski JA; Anderson M Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468 [TBL] [Abstract][Full Text] [Related]
6. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction. Sharma P Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464 [TBL] [Abstract][Full Text] [Related]
7. Barrett's Esophagus. Pascu O; Lencu M Rom J Gastroenterol; 2004 Sep; 13(3):219-22. PubMed ID: 15470535 [TBL] [Abstract][Full Text] [Related]
8. Should patients with Barrett's oesophagus be kept under surveillance? The case for. Armstrong D Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826 [TBL] [Abstract][Full Text] [Related]
9. Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia. Armstrong D Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():40-7; discussion 61-2. PubMed ID: 15456463 [TBL] [Abstract][Full Text] [Related]
10. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Todd JA; Basu KK; de Caestecker JS Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832 [TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus. Shalauta MD; Saad R Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957 [TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus: a review. Gadour M; Ayoola EA Trop Gastroenterol; 2002; 23(4):157-61. PubMed ID: 12833699 [TBL] [Abstract][Full Text] [Related]
13. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506 [TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease and Barrett's esophagus. Koop H Endoscopy; 2004 Feb; 36(2):103-9. PubMed ID: 14765307 [TBL] [Abstract][Full Text] [Related]
15. Molecular evaluation of ablative therapy of Barrett's oesophagus. Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364 [TBL] [Abstract][Full Text] [Related]
16. [Barrett's esophagus: epidemiology diagnosis and treatment in 2005]. Frossard JL; Dumonceau JM Rev Med Suisse; 2005 Sep; 1(31):2037-8, 2040-1. PubMed ID: 16212006 [TBL] [Abstract][Full Text] [Related]